New MRI Contrast Agent is Developed
Posted on: Tuesday, 5 June 2007, 15:00 CDT
South Korean scientists have developed a magnetic resonance imaging contrast agent using manganese oxide nanoparticles.
The researchers -- led by Taeghwan Hyeon at Seoul National University and Jung Hee Lee at the Samsung Medical Center -- note conventional gadolinium complexes used as MRI contrast agents cannot reveal anatomic structures. But the newly developed nanoparticles produced images of the anatomic structures of mouse brains that are as clear as those obtained by histological examination.
We have developed the first truly biocompatible MRI contrast agent for anatomical brain imaging, Lee and Hyeon said, adding they hope the new contrast agent will allow better research and diagnosis of brain diseases involving the central nervous system, such as Alzheimer's disease, Parkinson's disease, strokes and tumors.
Furthermore, the researchers said they were able to attach antibodies to the manganese oxide nanoparticles so they recognize and specifically bind to receptors on the surface of breast cancer cells. In mouse brains with breast cancer metastases, the tumors were clearly highlighted.
The scientists said the same principle should allow other disease-related changes or physiological systems to be visualized by using the appropriate antibodies.
The study appears in the journal Angewandte Chemie.
Source: United Press International
Related Articles
- Transplanted Neurons Develop Disease-Like Pathology In Huntington's Patients
- C-section Births Cause Genetic Changes That Could Increase Odds For Developing Diseases In Later Life
- Eating Habits, Exercise Vital for Development
- Covidien Signs Contrast Imaging Agent Agreement With MedAssets Supply Chain Systems
- Study Shows Advantages of Complete Phase Ib Trial Over Separate Phase I Trials
- Kyowa Releases Results to Phase III Clinical Studies of an Anti-Parkinson's Disease Drug Istradefylline (KW-6002) Conducted Overseas
- Attack on U.S. Food Supply 'Easy,' Senators Warn
- Development and Validation of a Survey-Based COPD Severity Score*
- Obesity and Insulin Resistance Age Cells
- China is 'Weak and Vulnerable' to Bird Flu Outbreak
 |
 |
User Comments (0)
RSS Feeds